0001410384-21-000004.txt : 20210202
0001410384-21-000004.hdr.sgml : 20210202
20210202165320
ACCESSION NUMBER: 0001410384-21-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210129
FILED AS OF DATE: 20210202
DATE AS OF CHANGE: 20210202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Flake Matthew P
CENTRAL INDEX KEY: 0001597592
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36350
FILM NUMBER: 21582286
MAIL ADDRESS:
STREET 1: 13785 RESEARCH BLVD.
STREET 2: SUITE 150
CITY: AUSTIN
STATE: TX
ZIP: 78750
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Q2 Holdings, Inc.
CENTRAL INDEX KEY: 0001410384
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 202706637
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13785 RESEARCH BOULEVARD
STREET 2: SUITE 150
CITY: Austin
STATE: TX
ZIP: 78750
BUSINESS PHONE: 512-275-0072
MAIL ADDRESS:
STREET 1: 13785 RESEARCH BOULEVARD
STREET 2: SUITE 150
CITY: Austin
STATE: TX
ZIP: 78750
FORMER COMPANY:
FORMER CONFORMED NAME: CBG Holdings, Inc.
DATE OF NAME CHANGE: 20120103
FORMER COMPANY:
FORMER CONFORMED NAME: CBG Holdings Inc
DATE OF NAME CHANGE: 20070821
4
1
wf-form4_161230277676896.xml
FORM 4
X0306
4
2021-01-29
0
0001410384
Q2 Holdings, Inc.
QTWO
0001597592
Flake Matthew P
13785 RESEARCH BLVD.
SUITE 150
AUSTIN
TX
78750
1
1
0
0
President and CEO
Common Stock
2021-01-29
4
M
0
10000
20.19
A
279767
D
Common Stock
2021-01-29
4
S
0
10000
129.67
D
269767
D
Employee Stock Option (right to buy)
20.19
2021-01-29
4
M
0
10000
0
D
2016-02-20
2022-02-20
Common Stock
10000.0
7333
D
Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.98 to $131.34 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This option grant vested as to 1/4 of the total option grant on February 20, 2016, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests.
M. Scott Kerr, as attorney-in-fact
2021-02-02